These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19093126)

  • 1. [ANCA-associated vasculitides. Classifying the disease and its activity according to EULAR/EUVAS recommendations].
    Holle JU; Lamprecht P
    Z Rheumatol; 2009 Feb; 68(1):75-80. PubMed ID: 19093126
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards diagnostic criteria for the ANCA-associated vasculitides.
    Luqmani RA
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S57. PubMed ID: 17428369
    [No Abstract]   [Full Text] [Related]  

  • 3. Discussion of the 2007 British Society for Rheumatology guidelines for management of ANCA-associated vasculitis.
    Villa-Forte A; Hoffman GS
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):284-5. PubMed ID: 18446138
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides.
    Tervaert JW; Stegeman CA; Kallenberg CG
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):241-5. PubMed ID: 8946592
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic classification of antineutrophil cytoplasmic autoantibody-associated vasculitides.
    Jennette JC; Falk RJ
    Am J Kidney Dis; 1991 Aug; 18(2):184-7. PubMed ID: 1867177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of ANCA-associated vasculitides: old hypotheses and new insights.
    Hänsch GM; Iking-Konert C; Andrassy K
    Clin Nephrol; 2005 Dec; 64(6):460-4. PubMed ID: 16370160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antineutrophil cytoplasmic antibody-associated vasculitides.
    Seo P; Stone JH
    Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of antineutrophil cytoplasmic antibodies.
    Rus V; Handwerger BS
    Curr Rheumatol Rep; 2000 Oct; 2(5):383-9. PubMed ID: 11123087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
    Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
    [No Abstract]   [Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial ANCA testing has limited value during the follow-up of disease activity in patients with ANCA-associated vasculitis.
    Lesavre P; Kyndt X; Vanhille P; Reumaux D; Guillevin L; Noël LH
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):246-8. PubMed ID: 8946593
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides.
    Csernok E
    Autoimmun Rev; 2003 May; 2(3):158-64. PubMed ID: 12848957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in pathogenesis and therapy of vasculitis syndrome.
    Origuchi T; Ichinose K; Tamai M; Nakamura H; Kawakami A; Eguchi K
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):432-43. PubMed ID: 18174672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?
    Brons RH; Kallenberg CG; Tervaert JW
    Rheum Dis Clin North Am; 2001 Nov; 27(4):833-48. PubMed ID: 11723767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology and new therapeutic considerations in ANCA-associated vasculitides.
    Gross WL
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S47-8. PubMed ID: 15309793
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan.
    Joh K; Muso E; Shigematsu H; Nose M; Nagata M; Arimura Y; Yumura W; Wada T; Nitta K; Makino H; Taguma Y; Kaneoka H; Suzuki Y; Kobayashi M; Koyama A; Usui J; Hashimoto H; Ozaki S; Tomino Y; Yamagata K
    Clin Exp Nephrol; 2008 Aug; 12(4):277-291. PubMed ID: 18425690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neutrophil polynuclear anticytoplasmic antibodies in systemic vasculitides].
    Guillevin L
    Rev Mal Respir; 2000 Jun; 17(3):623-8. PubMed ID: 10951957
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antineutrophil cytoplasmic antibody (ANCA). Diagnostic tool in small vessel vasculitis].
    Skogh T; Dahle L
    Lakartidningen; 1997 Mar; 94(10):854-7. PubMed ID: 9102513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.